Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05264545

Non-Guided vs. Guided Surgery to Immediately Loaded PrimeTaper Implants in Partially Edentulous Patients

A 510k approved dental device for subjects requiring single or multiple tooth replacement with implants where immediate restoration/loading is preferred.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

25 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

McClain and Schallhorn Periodontics and Implant Dentistry, Aurora, Colorado, United States

Loading trial locations.

About this study

The rationale for this study is to provide scientific data on the clinical performance and patient reported outcomes of the PrimeTaper EV implant when utilizing non-guided vs guided surgical technique. The PrimeTaper EV implant has the OsseoSpeed surface, which is especially indicated for use in soft bone applications where implants with other surface treatments may be less effective.

The main interests of this study are to assess the survival and the success rates of the implants supporting maxillary or mandibular fixed single or 2-fixture restorations after 1, 2, 3, 4 and 5 years in function

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject ≥25 years.
  • Subject has signed and dated the informed consent form prior to any study procedures.
  • History of either a healed edentulous area or single or multiple teeth requiring extraction and in need of a single or fixed bridge prosthetic restoration and where immediate restoration/loading is preferred.
  • Opposing jaw in the treatment area meets any of the following stable occlusal conditions:

Complete denture Partial removable denture Fixed bridges and/or crowns Natural dentition

Exclusion criteria

Any of the following is regarded as a criterion for exclusion from the study (all criteria apply at study inclusion, but criteria numbered 1-4 also apply during the entire study period):

  • Unlikely to be able to comply with study procedures, according to the Investigator's judgment.
  • Subject is not willing to participate in the study or not able to understand the content of the study.
  • Involved in the planning and conduct of the study.
  • Unable or unwilling to return for follow-up visits for a period of 5 years.
  • Has an uncontrolled pathological process in the oral cavity (e.g. untreated periodontal disease, uncontrolled caries, severe malocclusion, etc.).
  • Known or suspected current malignancy.
  • History of radiation therapy in the head and neck region.
  • History of chemotherapy within 5 years prior to surgery.
  • Systemic or local disease or condition that could compromise post-operative healing and/or osseointegration (e.g., uncontrolled diabetes mellitus as reported by the subject).
  • Use of systemic corticosteroids, IV bisphosphonates or any other medication that could compromise post-operative healing and/or osseointegration.
  • Current alcohol and/or drug abuse.
  • Smoking more than 10 cigarettes of any type per day.
  • Current need for major bone grafting and/or augmentation in the planned implant area (esthetic augmentation and minor facial grafting are allowed).
  • Known pregnancy, or plans to become pregnant during the study period of 5 years
  • Participation in another clinical study within the previous 6 months that may interfere with the present study.

Post-surgical Exclusion criteria

  • Insufficient primary stability, as judged by the investigator, of the implant(s).
  • Severe non-compliance to CIP as judged by the Investigator and/or Dentsply Sirona Implants.

Treatment and study plan

PrimeTaper EV

Device

The PrimeTaper EV Implant is a screw shaped dental implant with a defined surface achieved through grit blasting, followed by a process involving a treatment in diluted hydrofluoric acid. There is a conical connection between the implants and the abutments for a tight and stable connection.

Primary outcomes

  1. To evaluate implant survival rate at 1 year after final restoration attachment (screw retained when feasible) with single and multiple (fixed bridges) PrimeTaper EV implant(s) utilizing non-guided versus guided surgery

    Time frame: 1 year after final restoration

    Number of remaining implants counted clinically and radiographically, i.e. 'Yes' or 'No' for each implant where 'Yes' means that the implant is still remaining and 'No' means that the implant is not remaining.

Secondary outcomes

  1. Implant stability by manual clinical examination

    Time frame: throughout study, up to the 5 year follow up

    Mobility (manual stability) will be assessed by a percussion test for resonance indicative of bone to implant contact vertically and laterally.

  2. Implant survival rate

    Time frame: 2, 3, 4, and 5 years after final restoration attachment

    Number of remaining implants counted clinically and radiographically, i.e. 'Yes' or 'No' for each implant where 'Yes' means that the implant is still remaining and 'No' means that the implant is not remaining.

  3. Maintenance of marginal bone levels on patient- and implant level.

    Time frame: throughout study up to the 5 year follow up visit

    Changes (mm) in marginal bone level (MBL)

  4. Condition of the peri-implant mucosa (Plaque Index)

    Time frame: measured at 12 days (no BOP, PPD), 16 weeks, 20 weeks, 6 months, 1,2,3,4,5 years,

    Plaque index will be measured following implant placement by visual inspection using a scoring system of 0-1, 0 being no plaque is present and 1 being plaque is present.

  5. Condition of the peri-implant mucosa (Recession)

    Time frame: measured at 12 days (no BOP, PPD), 16 weeks, 20 weeks, 6 months, 1,2,3,4,5 years,

    Recession will be measured following implant placement by placing a probe between the tooth and gum to record depth of recession in millimeters from the crown margin to the gingival margin rounded to the nearest 0.5 mm.

  6. Condition of the peri-implant mucosa (Suppuration by visual inspection).

    Time frame: measured at 12 days (no BOP, PPD), 16 weeks, 20 weeks, 6 months, 1,2,3,4,5 years,

    Suppuration presence or absence will be measured following implant placement by using a scoring system of 0-1. 0 being no suppuration and 1 being suppuration is present. It is being identified by visual inspection and palpitation of moderate inflammation.

  7. Condition of the peri-implant mucosa.

    Time frame: measured at 12 days, 20 weeks, 1,2,3,4,5 years

    Keratinized Tissue Width (KTw) will be measures following implant placement

  8. Patient Reported Outcomes (PROs)

    Time frame: 20 weeks, 6 months, years 1,2,3,4,5

    subjects will be interviewed to ask about Discomfort using a 0 (no discomfort)-10 (as much discomfort as i have ever felt) point grading system

  9. Patient Reported Outcomes (PROs)

    Time frame: 20 weeks, 6 months, years 1,2,3,4,5

    subjects will be interviewed to ask about Esthetics using a 0 (completely displeased)-10 (completely pleased) point grading system

  10. Patient Reported Outcomes (PROs)

    Time frame: 20 weeks, 6 months, years 1,2,3,4,5

    subjects will be interviewed to ask about Satisfaction using a 0 (completely dissatisfied) -10 (completely satisfied) point grading system

  11. Investigator Assessment of the Implant-Prosthetic Complex

    Time frame: 20 weeks and 5 years.

    Evaluation of the Esthetic outcome on a 4 point scale (1=very good, 2= good, 3=acceptable, 4=not acceptable)

  12. Investigator Assessment of the Implant-Prosthetic Complex

    Time frame: 20 weeks and 5 years.

    Evaluation of Function a 4 point scale (1=very good, 2= good, 3=acceptable, 4=not acceptable)

  13. Investigator Assessment of the Implant-Prosthetic Complex

    Time frame: 20 weeks and 5 years.

    Evaluation of Gingival Health n a 4 point scale (1=very good, 2= good, 3=acceptable, 4=not acceptable)

  14. Investigator Assessment of the Implant-Prosthetic Complex

    Time frame: 20 weeks and 5 years.

    Evaluation of Bone Level of the permanent prosthetic restoration n a 4 point scale (1=very good, 2= good, 3=acceptable, 4=not acceptable)

  15. Implant success

    Time frame: throughout study up to the 5 year follow up visit

    Proportion of implants with the derived answer 'No' on the occurrence of "pain", "mobility", "≥2 mm radiological bone loss from initial placement", "infection", "radiolucency" and "6" or greater on the Subject Satisfaction PRO Question and "Very good", "good" or "acceptable" on each Investigator Evaluation of Esthetic Outcome, Function, Gingival Health, Bone Level

  16. Prosthetic survival

    Time frame: 5 years after final restoration attachment

    Proportion of original permanent prosthetic restorations still in place at the 5 years after final restoration attachment.

  17. Prosthetic success

    Time frame: 5 years after final restoration attachment.

    Analysis of successful permanent prosthetic restorations (implant-prosthetic complex); Number of suprastructure fractures, technical repairs 5 years after final restoration attachment.

Sponsors and collaborators

Lead sponsor

McGuire Institute

Industry

Collaborators

  • Dentsply Sirona Implants and Consumables

Registry information

Official study title

Prospective, Multicenter, Non-randomized, Controlled Clinical Study Utilizing Non-Guided vs. Guided Surgery to Immediately Loaded PrimeTaper Implants in Partially Edentulous Patients

Important dates

Study start
2022
Primary completion
2026
Study completion
2026
First posted
Mar 3, 2022
Registry last updated
Jun 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.